{
    "clinical_study": {
        "@rank": "117491", 
        "arm_group": [
            {
                "arm_group_label": "IQP-VV-102", 
                "arm_group_type": "Active Comparator", 
                "description": "2 tablets twice a day"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 tablets twice a day"
            }
        ], 
        "brief_summary": {
            "textblock": "Subjects are randomized to either IQP-VV-102 or a matching placebo. Over 12 weeks, the\n      subjects' body weight, body fat and safety parameters are monitored"
        }, 
        "brief_title": "Efficacy and Safety of IQP-VV-102 in Weight Management", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Obesity", 
            "Overweight"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Overweight"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 to 60 years\n\n          -  25 kg/m2 \u2264 BMI \u2264 35 kg/m2\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Known sensitivity to sources of the active ingredients and excipients\n\n          -  Pregnancy or nursing\n\n          -  Inability to comply with study requirements, e.g. due to language difficulties\n\n          -  Participation in another study during the last 30 days of the screening visit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681069", 
            "org_study_id": "INQ/009712"
        }, 
        "intervention": [
            {
                "arm_group_label": "IQP-VV-102", 
                "intervention_name": "IQP-VV-102", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "10709"
                }, 
                "name": "Barbara Grube"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Measured in kg using calibrated weighing scales", 
            "measure": "Difference in mean loss of body weight", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681069"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured in kg using calibrated weighing scales", 
                "measure": "Difference in mean loss of body fat", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Measured in cm", 
                "measure": "Waist circumference", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Full blood count and clinical chemistry", 
                "measure": "Clinical lab measurements", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "InQpharm Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "InQpharm Group", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}